Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Elecoglipron

A Study to Investigate the Effect of Elecoglipron on Rosuvastatin and Atorvastatin in Healthy Participants

AstraZeneca · Phase 1 · Active, not recruiting · Enrollment 48

NCT07534592

ArmPopulationDoseWeeksEstimandWeight change
Group 1: Period 1Healthy Participantsn/rn/rn/rn/r
Group 1: Period 2Healthy Participantsn/rn/rn/rn/r
Group 1: Period 3Healthy Participantsn/rn/rn/rn/r
Group 1: Period 4Healthy Participantsn/rn/rn/rn/r
Group 1: Period 5Healthy Participantsn/rn/rn/rn/r
Group 1: Period 6Healthy Participantsn/rn/rn/rn/r
Group 2: Period 1Healthy Participantsn/rn/rn/rn/r
Group 2: Period 2Healthy Participantsn/rn/rn/rn/r
Group 2: Period 3Healthy Participantsn/rn/rn/rn/r
Group 2: Period 4Healthy Participantsn/rn/rn/rn/r
Group 2: Period 5Healthy Participantsn/rn/rn/rn/r
Group 2: Period 6Healthy Participantsn/rn/rn/rn/r
Group 2: Period 7Healthy Participantsn/rn/rn/rn/r